C&C Group Valuation
Is CCRL undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
3/6Valuation Score 3/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of CCRL when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: CCRL (£1.49) is trading above our estimate of fair value (£1.32)
Significantly Below Fair Value: CCRL is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for CCRL?
Key metric: As CCRL is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
What is CCRL's PS Ratio? | |
---|---|
PS Ratio | 0.4x |
Sales | €1.65b |
Market Cap | €673.58m |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 0.5x |
Enterprise Value/EBITDA | 10.5x |
PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does CCRL's PS Ratio compare to its peers?
Company | Forward PS | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 2.9x | ||
CDGP Chapel Down Group | 3.7x | n/a | UK£60.9m |
ART Artisanal Spirits | 1.2x | 8.8% | UK£28.9m |
GUS Gusbourne | 3.6x | n/a | UK£25.3m |
NICL Nichols | 2.8x | 3.6% | UK£473.1m |
CCRL C&C Group | 0.4x | 4.2% | UK£562.9m |
Price-To-Sales vs Peers: CCRL is good value based on its Price-To-Sales Ratio (0.4x) compared to the peer average (2.9x).
Price to Sales Ratio vs Industry
How does CCRL's PS Ratio compare vs other companies in the European Beverage Industry?
3 Companies | Price / Sales | Estimated Growth | Market Cap |
---|---|---|---|
3 Companies | Estimated Growth | Market Cap | |
---|---|---|---|
Price-To-Sales vs Industry: CCRL is good value based on its Price-To-Sales Ratio (0.4x) compared to the European Beverage industry average (1.3x).
Price to Sales Ratio vs Fair Ratio
What is CCRL's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PS Ratio | 0.4x |
Fair PS Ratio | 0.6x |
Price-To-Sales vs Fair Ratio: CCRL is good value based on its Price-To-Sales Ratio (0.4x) compared to the estimated Fair Price-To-Sales Ratio (0.6x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | UK£1.49 | UK£2.02 +35.3% | 24.9% | UK£3.01 | UK£1.65 | n/a | 5 |
Nov ’25 | UK£1.48 | UK£2.02 +35.9% | 24.9% | UK£3.01 | UK£1.65 | n/a | 5 |
Oct ’25 | UK£1.60 | UK£2.00 +24.7% | 25.1% | UK£2.99 | UK£1.65 | n/a | 5 |
Sep ’25 | UK£1.56 | UK£2.08 +33.3% | 23.9% | UK£3.04 | UK£1.68 | n/a | 5 |
Aug ’25 | UK£1.58 | UK£2.08 +31.7% | 22.7% | UK£2.99 | UK£1.65 | n/a | 5 |
Jul ’25 | UK£1.59 | UK£2.08 +30.8% | 22.8% | UK£3.00 | UK£1.65 | n/a | 5 |
Jun ’25 | UK£1.69 | UK£2.05 +20.8% | 25.0% | UK£3.00 | UK£1.45 | n/a | 5 |
May ’25 | UK£1.66 | UK£2.04 +22.6% | 25.2% | UK£2.99 | UK£1.44 | n/a | 5 |
Apr ’25 | UK£1.65 | UK£2.04 +23.7% | 25.3% | UK£2.99 | UK£1.44 | n/a | 5 |
Mar ’25 | UK£1.48 | UK£2.03 +37.8% | 25.3% | UK£2.99 | UK£1.44 | n/a | 5 |
Feb ’25 | UK£1.51 | UK£2.03 +34.6% | 25.5% | UK£3.00 | UK£1.45 | n/a | 5 |
Jan ’25 | UK£1.52 | UK£1.94 +27.6% | 29.0% | UK£3.00 | UK£1.39 | n/a | 5 |
Dec ’24 | UK£1.35 | UK£1.95 +44.0% | 28.7% | UK£3.00 | UK£1.40 | n/a | 5 |
Nov ’24 | UK£1.39 | UK£2.09 +50.6% | 26.0% | UK£3.00 | UK£1.65 | UK£1.48 | 4 |
Oct ’24 | UK£1.39 | UK£2.10 +50.7% | 26.1% | UK£3.02 | UK£1.66 | UK£1.60 | 4 |
Sep ’24 | UK£1.35 | UK£2.07 +53.9% | 26.5% | UK£3.00 | UK£1.65 | UK£1.56 | 4 |
Aug ’24 | UK£1.42 | UK£2.07 +46.5% | 26.5% | UK£3.00 | UK£1.65 | UK£1.58 | 4 |
Jul ’24 | UK£1.26 | UK£2.06 +63.6% | 25.9% | UK£2.96 | UK£1.63 | UK£1.59 | 4 |
Jun ’24 | UK£1.43 | UK£2.06 +44.4% | 25.9% | UK£2.96 | UK£1.63 | UK£1.69 | 4 |
May ’24 | UK£1.56 | UK£1.93 +23.4% | 2.6% | UK£2.00 | UK£1.89 | UK£1.66 | 3 |
Apr ’24 | UK£1.57 | UK£1.93 +23.0% | 2.6% | UK£2.00 | UK£1.89 | UK£1.65 | 3 |
Mar ’24 | UK£1.48 | UK£2.24 +50.7% | 17.2% | UK£2.88 | UK£1.90 | UK£1.48 | 4 |
Feb ’24 | UK£1.60 | UK£2.24 +39.8% | 17.2% | UK£2.88 | UK£1.90 | UK£1.51 | 4 |
Jan ’24 | UK£1.77 | UK£2.46 +39.0% | 12.5% | UK£2.88 | UK£2.07 | UK£1.52 | 4 |
Dec ’23 | UK£1.84 | UK£2.46 +33.8% | 12.5% | UK£2.88 | UK£2.07 | UK£1.35 | 4 |
Nov ’23 | UK£1.65 | UK£2.45 +48.2% | 12.3% | UK£2.86 | UK£2.07 | UK£1.39 | 4 |
Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.
Discover undervalued companies
Ebro Foods
€2.4b
Operates as a food company in Spain, rest of Europe, the United States, Canada, and internationally.
0NYH
€15.96
7D
1.4%
1Y
1.7%
Nestlé
CHF 195.0b
Operates as a food and beverage company.
NESNZ
CHF 75.92
7D
-0.8%
1Y
-23.8%
Associated British Foods
UK£16.2b
Operates as a diversified food, ingredients, and retail company worldwide.
ABFL
UK£22.07
7D
2.0%
1Y
-7.2%